Lynda Ratmeyer

1.2k total citations
9 papers, 1.0k citations indexed

About

Lynda Ratmeyer is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Lynda Ratmeyer has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Infectious Diseases and 2 papers in Organic Chemistry. Recurrent topics in Lynda Ratmeyer's work include DNA and Nucleic Acid Chemistry (7 papers), RNA and protein synthesis mechanisms (5 papers) and HIV/AIDS drug development and treatment (3 papers). Lynda Ratmeyer is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), RNA and protein synthesis mechanisms (5 papers) and HIV/AIDS drug development and treatment (3 papers). Lynda Ratmeyer collaborates with scholars based in United States. Lynda Ratmeyer's co-authors include W. David Wilson, Min Zhao, David W. Boykin, Lucjan Strękowski, Ravi Vinayak, Farial A. Tanious, James M. Veal, W. David Wilson, Sergei Gryaznov and Larry DeDionisio and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Lynda Ratmeyer

9 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynda Ratmeyer United States 8 803 238 216 84 72 9 1.0k
Guozhi Tang China 18 533 0.7× 149 0.6× 242 1.1× 97 1.2× 29 0.4× 30 1.0k
Richard J. Guajardo United States 13 476 0.6× 158 0.7× 116 0.5× 129 1.5× 227 3.2× 15 726
Stephen A. Salisbury United Kingdom 19 1.4k 1.8× 97 0.4× 165 0.8× 120 1.4× 102 1.4× 37 1.8k
J. Lhomme France 15 1.0k 1.3× 188 0.8× 329 1.5× 112 1.3× 19 0.3× 52 1.3k
John F. Domsic United States 15 700 0.9× 192 0.8× 250 1.2× 82 1.0× 37 0.5× 22 1.0k
John E. Hanson United States 9 586 0.7× 96 0.4× 331 1.5× 46 0.5× 27 0.4× 13 960
Seved Lövgren Sweden 12 779 1.0× 84 0.4× 256 1.2× 125 1.5× 42 0.6× 17 1.2k
Mitsuharu Kotera France 17 705 0.9× 68 0.3× 388 1.8× 114 1.4× 28 0.4× 48 1.0k
Y. Katsube Japan 11 296 0.4× 92 0.4× 83 0.4× 102 1.2× 57 0.8× 45 638
Alexandre S. Boutorine France 23 1.2k 1.5× 168 0.7× 511 2.4× 325 3.9× 24 0.3× 63 1.7k

Countries citing papers authored by Lynda Ratmeyer

Since Specialization
Citations

This map shows the geographic impact of Lynda Ratmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynda Ratmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynda Ratmeyer more than expected).

Fields of papers citing papers by Lynda Ratmeyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynda Ratmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynda Ratmeyer. The network helps show where Lynda Ratmeyer may publish in the future.

Co-authorship network of co-authors of Lynda Ratmeyer

This figure shows the co-authorship network connecting the top 25 collaborators of Lynda Ratmeyer. A scholar is included among the top collaborators of Lynda Ratmeyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynda Ratmeyer. Lynda Ratmeyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ratmeyer, Lynda, Maria L. Zapp, Michael R. Green, et al.. (1996). Inhibition of HIV-1 Rev−RRE Interaction by Diphenylfuran Derivatives. Biochemistry. 35(42). 13689–13696. 54 indexed citations
2.
Wilson, W. David, Lynda Ratmeyer, Min Zhao, et al.. (1996). Design and analysis of RNA structure-specific agents as potential antivirals. Journal of Molecular Recognition. 9(2). 187–196. 12 indexed citations
3.
Zhao, Min, Lynda Ratmeyer, Shijie Yao, et al.. (1995). Small changes in cationic substituents of diphenylfuran derivatives have major effects on the binding affinity and the binding mode with RNA helical duplexes. Bioorganic & Medicinal Chemistry. 3(6). 785–794. 29 indexed citations
4.
Gryaznov, Sergei, D. H. Lloyd, Ronald G. Schultz, et al.. (1995). Oligonucleotide N3'-->P5' phosphoramidates.. Proceedings of the National Academy of Sciences. 92(13). 5798–5802. 134 indexed citations
5.
Ratmeyer, Lynda, et al.. (1994). Sequence Specific Thermodynamic and Structural Properties for DNA.cntdot.RNA Duplexes. Biochemistry. 33(17). 5298–5304. 152 indexed citations
6.
Wilson, W. David, Lynda Ratmeyer, Marek Cegła, et al.. (1994). ChemInform Abstract: Bulged‐Base Nucleic Acids as Potential Targets for Antiviral Drug Action. ChemInform. 25(30). 1 indexed citations
7.
Wilson, W. David, Lynda Ratmeyer, Min Zhao, Lucjan Strękowski, & David W. Boykin. (1993). The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strength. Biochemistry. 32(15). 4098–4104. 387 indexed citations
8.
Tanious, Farial A., et al.. (1992). DAPI (4',6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites. Biochemistry. 31(12). 3103–3112. 224 indexed citations
9.
Ratmeyer, Lynda, et al.. (1992). An ethidium analog that binds with high specificity to a base-bulged duplex from the TAR RNA region of the HIV-1 genome. Journal of Medicinal Chemistry. 35(5). 966–968. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026